These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13366721)

  • 41. Staphylococcal resistance to ristocetin, oleandomycin, and novobiocin.
    HSIE JY; NUSSER W; EPSTEIN S; VAN MAREN H; OZOG S
    Antibiot Chemother (Northfield); 1958 Dec; 8(12):607-14. PubMed ID: 24545054
    [No Abstract]   [Full Text] [Related]  

  • 42. Novobiocin; antistaphylococcal action in postsurgical diarrheas.
    FINDLAY CW; JOHNSON BA
    Antibiot Annu; 1956-1957; ():202-7. PubMed ID: 13425380
    [No Abstract]   [Full Text] [Related]  

  • 43. [Considerations on the discrepancies between in vitro sensitivity and clinical results in antibiotic therapy of infections caused by Staphylococcus pyogenes aureus].
    GRASSI GC
    Biol Lat; 1958; 11(2):273-81. PubMed ID: 13546207
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of the routine use of novobiocin and spiramycin in combination on the antibiotic sensitiveness of hospital Staphylococci.
    LEPPER MH; DOWLING HF; JACKSON GG; SPIES HW; MELLODY M
    Antibiot Annu; 1956-1957; ():640-7. PubMed ID: 13425444
    [No Abstract]   [Full Text] [Related]  

  • 45. Antibiotic for staphylococcal infections.
    FINLAND M
    Med Clin North Am; 1958 Sep; 42(5):1179-94. PubMed ID: 13599740
    [No Abstract]   [Full Text] [Related]  

  • 46. The in vitro antibiotic activity of novobiocin on M. pyogenes and some intestinal gram-negative bacteria.
    COPPO A
    Antibiot Chemother (Northfield); 1957 Jun; 7(6):297-305. PubMed ID: 24544434
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical observations on the use of novobiocin in penicillin-resistant staphylococcal septicemia.
    COLVILLE JM; GALE HH; COX F; QUINN EL
    Antibiot Annu; 1957-1958; 5():920-6. PubMed ID: 13521914
    [No Abstract]   [Full Text] [Related]  

  • 48. The current status of erythromycin, kanamycin, novobiocin, oleandomycin, ristocetin, and vancomycin, with particular reference to their use in staphylococcal disease; panel discussion.
    FINLAND M; FOLTZ E; GERACI JE; KIRBY WM; QUINN EL; ROMANSKY MJ; YOW EM
    Antibiot Annu; 1958-1959; 6():1051-72. PubMed ID: 13637882
    [No Abstract]   [Full Text] [Related]  

  • 49. THE OBSTINATE Staphylococcus.
    Med World; 1956 Aug; 85(2):128-9. PubMed ID: 13358373
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin.
    SCHNEIERSON SS; AMSTERDAM D
    Antibiot Chemother (Northfield); 1957 May; 7(5):251-4. PubMed ID: 24544426
    [No Abstract]   [Full Text] [Related]  

  • 51. Correlation between in vitro studies and response to antibiotic therapy in staphylococcic bacteremia.
    ABBOUD FM; WAISBREN BA
    AMA Arch Intern Med; 1959 Aug; 104(2):226-33. PubMed ID: 13669776
    [No Abstract]   [Full Text] [Related]  

  • 52. The assay of antibiotics in combination using resistant strains of Micrococcus pyognes var. aureus.
    TANGUAY AE; BOGERT AB; WEHNER DC
    Antibiot Chemother (Northfield); 1955 Apr; 5(4):232-7. PubMed ID: 24543472
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of agar on the inhibition of Micrococcus pyogenes var. aureus by chlortetracycline and other antibiotics.
    IYER R; IYER V
    Antibiot Chemother (Northfield); 1960 Jul; 10():409-13. PubMed ID: 14406187
    [No Abstract]   [Full Text] [Related]  

  • 54. Hospital cross-infections with staphylococci resistant to several antibiotics.
    CLARKE SK; DALGLEISH PG; GILLESPIE WA
    Lancet; 1952 Jun; 1(6719):1132-5. PubMed ID: 14928602
    [No Abstract]   [Full Text] [Related]  

  • 55. [Synergism and antagonism of antibiotics; experimental research with Staphylococcus pyogenes aureus of Oxford].
    LENTI G; ODDONE I; FAZIO M; CALCIATI A; JONA E
    G Batteriol Immunol; 1955; 48(5-6):224-38. PubMed ID: 13277778
    [No Abstract]   [Full Text] [Related]  

  • 56. Streptonivicin: laboratory and clinical studies in the pediatric age group.
    CORIELL LL; LIN FK
    Antibiot Annu; 1955-1956; 3():634-9. PubMed ID: 13355340
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro sensitivity of 300 strains of Micrococcus pyogenes isolated from carriers to seven antibiotics; the problem of the resistant Staphylococci in Chile.
    PAREDES L; VACCARO H; VALENZUELA E
    Antibiot Annu; 1955-1956; 3():623-33. PubMed ID: 13355339
    [No Abstract]   [Full Text] [Related]  

  • 58. Recent changes in sensitivity of Micrococcus pyogenes to various antibiotic agents.
    NEEDHAM GM; NICHOLS DR
    J Lab Clin Med; 1953 Jan; 41(1):150-6. PubMed ID: 13023106
    [No Abstract]   [Full Text] [Related]  

  • 59. Selection of stable multiple antibiotic-resistant variants of Micrococcus pyogenes in the absence of antibiotics.
    FUSILLO MH
    Antibiot Chemother (Northfield); 1956 Feb; 6(2):125-9. PubMed ID: 24543914
    [No Abstract]   [Full Text] [Related]  

  • 60. Moniliasis associated with staphylococcal infection after antibiotic therapy.
    DEPAPE AJ
    Can Med Assoc J; 1959 Feb; 80(3):205-7. PubMed ID: 13618824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.